In this model, we again saw only modest effects from the Meso-CAR T cells but observed more robust inhibition of tumor growth with the FAP-CAR T cells compared with MigR control and Meso-CAR T cells, monitored by non-invasive ultrasound imaging (Fig. 1k and Supplementary Fig. 2d–g). This evidence concerns the gene CXCR3 and neoplasm.